Skip to content
IJCBR|ISSN: 2521-0394
Log in
IJ
IJCBR
Original Research ArticlesPeer-reviewedOpen Access · CC BY 4.0

PSEUDOCHOLINESTERASE AS A PREDICTOR MARKER IN HYPOTHYROID PATIENTS

Kaushik GG1, Soni Reena2

  1. 1 Department of Biochemistry, J.L.N. Medical College, Ajmer, Rajasthan, India. (corresponding author)
  2. 2 Department of Biochemistry, J.L.N. Medical College, Ajmer, Rajasthan, India.

DOI: 10.31878/ijcbr.2018.43.06 · Published 2018-07-31 · pp. 27-29

Download PDF

Abstract

Introduction: Hypothyroidism is due to decreased circulating levels of Thyroid hormones and is caused by inadequate functioning of thyroid gland. Pseudocholinesterase (PCHE) is a nonspecific cholinesterase enzyme that hydrolyses choline based esters in plasma. The purpose of this study was to evaluate the serum level of PCHE in hypothyroid patients. Methodology: The present study was conducted on 100 newly diagnosed hypothyroid patients attending the Medical OPD. The results of patients were compared with 100 healthy controls of either sex of similar age group. Anthropometric measurements, T3, T4, TSH, PCHE & Cholesterol estimations were performed. Results: The mean serum PCHE (decrease) level was observed statistically highly significant (p<0.001) in hypothyroid patients as compared with healthy control subjects. A highly significant positive correlation between PCHE with T3 & T4 (p< 0.001) in hypothyroid cases. Conclusion: Serum Pseudocholinesterase may be helpful as biomarker in screening test  for hypothyroidism along with thyroid stimulating hormone.

References

  1. Kochupillai N. Clinical endocrinology in India. Current Science. 2000;79:1061-1067. [Crossref] [Google Scholar]
  2. Thompson JC, Whittaker M. Pseudocholinesterase activity in thyroid disease. J. Clin. Path. 1965;18:811 [Crossref] [Google Scholar]
  3. Porter WH. Carl AB, Edward RA editors, Tietz Textbook of clinical chemistry. Clinical Toxicology. 3rd edition, Elsevier Health Sciences. 1999;940. [Crossref] [Google Scholar]
  4. Vlaicu R, Popescu E, Popescu TA, Cucuianu M. Serum electrophoretic lipoprotein factors and pseudocholinesterase activity in thyroid disease.Endocrinologie. 1978;16(2):147-51. [Crossref] [Google Scholar]
  5. Sleeba SK, Prasad BNR, Bangera M. Pseudocholinesterase as a biochemical marker in hypothyroidism. Asian J Pharm Clin Res. 2013;16(2):9-20. [Crossref] [Google Scholar]
  6. WHO expert consultation. Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies. The Lancet, 2004; 157-163. [Crossref] [Google Scholar]
  7. Hollander CS. Clinical laboratory observation in cases of T3 toxicosis confirmed by radioimmunoassay. Lancet.1972;1:609-611. [Crossref] [Google Scholar]
  8. Schuurs AHWM and Van Weeman BK. Review Enzyme immunoassay. Clin. Chem. Acta.1977; 81:1 [Crossref] [Google Scholar]
  9. Uotila M, Ruoslahti E and Engvall E. J. Immunol. Methods. 1981;42:11-15. [Crossref] [Google Scholar]
  10. Charles h. Sawyer and John W. Everett. Liver synthesis of serum cholinesterase. Am j physiol. 1947;148(3):67583. [Crossref] [Google Scholar]
  11. Allian CC, Poon LS, Chan CSG, Richmond W and Fu P: Enzymatic determination of total serum cholesterol. Clin. Chem 1974; 20: 470. [Crossref] [Google Scholar]
  12. Thompson J.C and Whittakker M. Pseudocholinesterase activity in thyroid disease. J. clin. Path, 1965; 18, 811. [Crossref] [Google Scholar]